APA

Welford R. W. D., Mühlemann A., Garzotti M., Rickert V., Groenen P. M. A., Morand O., Üçeyler N. & Probst M. R. (20190328). Glucosylceramide synthase inhibition with lucerastat lowers globotriaosylceramide and lysosome staining in cultured fibroblasts from Fabry patients with different mutation types. : Human molecular genetics.

Chicago

Welford R W D, Mühlemann A, Garzotti M, Rickert V, Groenen P M A, Morand O, Üçeyler N and Probst M R. 20190328. Glucosylceramide synthase inhibition with lucerastat lowers globotriaosylceramide and lysosome staining in cultured fibroblasts from Fabry patients with different mutation types. : Human molecular genetics.

Harvard

Welford R. W. D., Mühlemann A., Garzotti M., Rickert V., Groenen P. M. A., Morand O., Üçeyler N. and Probst M. R. (20190328). Glucosylceramide synthase inhibition with lucerastat lowers globotriaosylceramide and lysosome staining in cultured fibroblasts from Fabry patients with different mutation types. : Human molecular genetics.

MLA

Welford R W D, Mühlemann A, Garzotti M, Rickert V, Groenen P M A, Morand O, Üçeyler N and Probst M R. Glucosylceramide synthase inhibition with lucerastat lowers globotriaosylceramide and lysosome staining in cultured fibroblasts from Fabry patients with different mutation types. : Human molecular genetics. 20190328.